Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Prepaid Assets of $29.7 million for Q1 2026, up 16.83% on a YoY basis from $25.4 million in Q1 2025, and down 30.27% quarter-over-quarter from $42.6 million in Q4 2025.
Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International has reported Prepaid Assets for 10 years, with the latest figure at $29.7 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 16.83% year-over-year to $29.7 million; the trailing twelve-month figure through Mar 2026 stood at $29.7 million (up 16.83% YoY), and the FY2025 full-year result was $42.6 million, up 112.18% from the prior year.
- Prepaid Assets for Q1 2026 stood at $29.7 million, down from $42.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $42.6 million in Q4 2025, with the low at $10.5 million in Q1 2022.
- Historically, Prepaid Assets has averaged $22.1 million across 5 years, with a median of $20.1 million in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets slipped 11.18% — and 2024, when it soared 116.67%.
- Kiniksa Pharmaceuticals International's Prepaid Assets stood at $10.5 million in 2022, then surged by 66.44% to $17.5 million in 2023, then climbed by 14.52% to $20.1 million in 2024, then jumped by 112.18% to $42.6 million in 2025, then slumped by 30.27% to $29.7 million in 2026.
- The last three Prepaid Assets figures came in at $29.7 million (Q1 2026), $42.6 million (Q4 2025), and $30.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kiniksa Pharmaceuticals International | 3.73 Bn | 3.26 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.71 Mn |
| Dec 31, 2025 | 42.61 Mn |
| Sep 30, 2025 | 30.29 Mn |
| Jun 30, 2025 | 32.44 Mn |
| Mar 31, 2025 | 25.43 Mn |
| Dec 31, 2024 | 20.08 Mn |
| Sep 30, 2024 | 33.95 Mn |
| Jun 30, 2024 | 26.95 Mn |
| Mar 31, 2024 | 13.77 Mn |
| Dec 31, 2023 | 17.54 Mn |
| Sep 30, 2023 | 26.40 Mn |
| Jun 30, 2023 | 12.44 Mn |
| Mar 31, 2023 | 13.16 Mn |
| Dec 31, 2022 | 10.54 Mn |
| Sep 30, 2022 | 15.31 Mn |
| Jun 30, 2022 | 14.01 Mn |
| Mar 31, 2022 | 10.52 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 8.50 Mn |
| Jun 30, 2021 | 9.80 Mn |